Login / Signup

Response of the trial innovation network to the COVID-19 pandemic.

Rachel Gottron GreenbergLori PooleDaniel E FordDaniel HanleyHarry P SelkerKaren LaneJ Michael DeanJeri BurrPaul A HarrisConsuelo H WilkinsGordon BernardTerri EdwardsDaniel K Benjamin
Published in: Journal of clinical and translational science (2021)
Our experience highlighted the benefits and challenges of a multi-institutional approach to clinical research during a pandemic.
Keyphrases
  • sars cov
  • coronavirus disease
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label